EP0871393A4 - In situ immunodetection of antigens - Google Patents
In situ immunodetection of antigensInfo
- Publication number
- EP0871393A4 EP0871393A4 EP96915750A EP96915750A EP0871393A4 EP 0871393 A4 EP0871393 A4 EP 0871393A4 EP 96915750 A EP96915750 A EP 96915750A EP 96915750 A EP96915750 A EP 96915750A EP 0871393 A4 EP0871393 A4 EP 0871393A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- antigens
- immunodetection
- situ
- situ immunodetection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0035—Vaccination diagnosis other than by injuring the skin, e.g. allergy test patches
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/025—Papovaviridae, e.g. papillomavirus, polyomavirus, SV40, BK virus, JC virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
- G01N2333/035—Herpes simplex virus I or II
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/38—Assays involving biological materials from specific organisms or of a specific nature from fungi from Aspergillus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
- G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
- G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/805—Optical property
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US447972 | 1995-05-20 | ||
US08/447,072 US5874226A (en) | 1995-05-22 | 1995-05-22 | In situ immunodetection of antigens |
PCT/US1996/006805 WO1996036274A1 (en) | 1995-05-20 | 1996-05-14 | In situ immunodetection of antigens |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0871393A1 EP0871393A1 (en) | 1998-10-21 |
EP0871393A4 true EP0871393A4 (en) | 1999-08-18 |
Family
ID=23774901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96915750A Ceased EP0871393A4 (en) | 1995-05-22 | 1996-05-14 | In situ immunodetection of antigens |
Country Status (7)
Country | Link |
---|---|
US (2) | US5874226A (en) |
EP (1) | EP0871393A4 (en) |
JP (1) | JP2002504222A (en) |
CN (1) | CN1146353C (en) |
AU (1) | AU5744696A (en) |
CA (1) | CA2221724A1 (en) |
WO (1) | WO1996036274A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010055581A1 (en) * | 1994-03-18 | 2001-12-27 | Lawrence Tamarkin | Composition and method for delivery of biologically-active factors |
CA2328503A1 (en) * | 1997-06-05 | 1998-12-10 | Royal Free Hospital School Of Medicine | Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder |
US7229841B2 (en) | 2001-04-30 | 2007-06-12 | Cytimmune Sciences, Inc. | Colloidal metal compositions and methods |
CA2224551A1 (en) * | 1998-02-25 | 1999-08-25 | Alex Hongsheng Chang | A quick in situ diagnostic method for detecting alimentary diseases |
US6558961B1 (en) * | 1998-09-04 | 2003-05-06 | Powderject Research Limited | Immunodiagnostics using particle delivery methods |
US20050148101A1 (en) * | 1999-01-23 | 2005-07-07 | Bamdad Cynthia C. | Interaction of colloid-immobilized species with species on non-colloidal structures |
WO2002001225A2 (en) * | 2000-06-23 | 2002-01-03 | Minerva Biotechnologies Corporation | Tandem signaling assay |
US7045286B2 (en) * | 2000-07-25 | 2006-05-16 | The Trustees Of The University Of Pennsylvania | Methods of detecting molecules expressing selected epitopes via fluorescent dyes |
US7524628B2 (en) * | 2000-07-25 | 2009-04-28 | The Trustees Of The University Of Pennsylvania | Method for detecting molecules expressing a selected epitope via fluorescent dyes |
US6743592B1 (en) * | 2000-07-25 | 2004-06-01 | The Trustees Of The University Of Pennsylvania | Methods, systems and kits for immuno-detection of epitopes expressed on molecules |
US6583722B2 (en) | 2000-12-12 | 2003-06-24 | Kimberly-Clark Worldwide, Inc. | Wetness signaling device |
US6603403B2 (en) | 2000-12-12 | 2003-08-05 | Kimberly-Clark Worldwide, Inc. | Remote, wetness signaling system |
US20020192676A1 (en) * | 2001-06-18 | 2002-12-19 | Madonna Angelo J. | Method for determining if a type of bacteria is present in a mixture |
US7341831B2 (en) | 2001-07-18 | 2008-03-11 | The Trustees Of The University Of Pennsylvania | Method for immuno-detection of epitopes |
SE520948C2 (en) * | 2002-01-16 | 2003-09-16 | Chemotechnique Mb Diagnostics | Allergy Test Element |
US7166425B2 (en) * | 2002-04-12 | 2007-01-23 | Colorado School Of Mines | Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
FR2845267B1 (en) * | 2002-10-08 | 2004-12-31 | Antialis | SKIN DIAGNOSTIC KIT FOR ATOPIA |
EP1694301A4 (en) * | 2003-12-02 | 2009-11-18 | Cytimmune Sciences Inc | Methods and compositions for the production of monoclonal antibodies |
US20050175584A1 (en) * | 2004-01-28 | 2005-08-11 | Paciotti Giulio F. | Functionalized colloidal metal compositions and methods |
US20110097702A1 (en) * | 2005-03-31 | 2011-04-28 | Voorhees Kent J | Methods and compositions for in situ detection of microorganisms on a surface |
WO2006105414A2 (en) * | 2005-03-31 | 2006-10-05 | Colorado School Of Mines | Apparatus and method for detecting microscopic organisms using microphage |
US20080154149A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of analyzing for at least one allergy |
US20080152592A1 (en) * | 2006-12-21 | 2008-06-26 | Bayer Healthcare Llc | Method of therapeutic drug monitoring |
US20100210932A1 (en) * | 2007-03-20 | 2010-08-19 | Bayer Healthcare Llc | Method of analyzing an analyte |
US20110014118A1 (en) * | 2007-09-21 | 2011-01-20 | Lawrence Tamarkin | Nanotherapeutic colloidal metal compositions and methods |
AU2008302035A1 (en) * | 2007-09-21 | 2009-03-26 | Cytimmune Sciences, Inc. | Nanotherapeutic colloidal metal compositions and methods |
US8697434B2 (en) * | 2008-01-11 | 2014-04-15 | Colorado School Of Mines | Detection of phage amplification by SERS nanoparticles |
US9441204B2 (en) * | 2008-04-03 | 2016-09-13 | Colorado School Of Mines | Compositions and methods for detecting Yersinia pestis bacteria |
EP2550362B1 (en) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
US10045759B2 (en) | 2010-04-22 | 2018-08-14 | Smarthealth, Inc. | Epicutaneous patch test chamber |
EP2691530B1 (en) | 2011-06-10 | 2018-03-07 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986003590A1 (en) * | 1984-12-06 | 1986-06-19 | Boehringer Biochemia Robin S.P.A. | Device and method for analysis of biological material |
US5203327A (en) * | 1988-09-08 | 1993-04-20 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
-
1995
- 1995-05-22 US US08/447,072 patent/US5874226A/en not_active Expired - Fee Related
-
1996
- 1996-05-14 CN CNB961955155A patent/CN1146353C/en not_active Expired - Fee Related
- 1996-05-14 EP EP96915750A patent/EP0871393A4/en not_active Ceased
- 1996-05-14 JP JP53495896A patent/JP2002504222A/en active Pending
- 1996-05-14 WO PCT/US1996/006805 patent/WO1996036274A1/en not_active Application Discontinuation
- 1996-05-14 AU AU57446/96A patent/AU5744696A/en not_active Abandoned
- 1996-05-14 CA CA002221724A patent/CA2221724A1/en not_active Abandoned
-
1998
- 1998-10-07 US US09/168,209 patent/US6080539A/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986003590A1 (en) * | 1984-12-06 | 1986-06-19 | Boehringer Biochemia Robin S.P.A. | Device and method for analysis of biological material |
US5203327A (en) * | 1988-09-08 | 1993-04-20 | Sudor Partners | Method and apparatus for determination of chemical species in body fluid |
Non-Patent Citations (1)
Title |
---|
See also references of WO9636274A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2221724A1 (en) | 1996-11-21 |
AU5744696A (en) | 1996-11-29 |
JP2002504222A (en) | 2002-02-05 |
CN1146353C (en) | 2004-04-21 |
US5874226A (en) | 1999-02-23 |
CN1195275A (en) | 1998-10-07 |
EP0871393A1 (en) | 1998-10-21 |
US6080539A (en) | 2000-06-27 |
WO1996036274A1 (en) | 1996-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0871393A4 (en) | In situ immunodetection of antigens | |
DE69604167D1 (en) | Vibrator | |
IL117177A0 (en) | Benzopyran-containing compounds and method for their use | |
GB9422383D0 (en) | Antibodies | |
EP0770941A4 (en) | Method and device for interpolating free-form surface | |
EP0851759A4 (en) | Compounds and methods | |
GB9526560D0 (en) | Use of 2-Amino-Heterocycles | |
GB2298713B (en) | Method and composition | |
IL119816A0 (en) | Absorbent structure and method for its manufacture | |
HK1005385A1 (en) | Radio-calibrated timepiece | |
ZA95701B (en) | Rivets-nails and methods for their implementation | |
EP0836617A4 (en) | Parevins and tachytegrins | |
ZA96725B (en) | Use of phenyclyclohexylcarboxamides | |
PL313021A1 (en) | Vibrator | |
EP0744125A3 (en) | Iodo-complex and its use | |
GB9523843D0 (en) | Cosmetic composition and method | |
GB9518522D0 (en) | Bridge device | |
GB9722556D0 (en) | Methods | |
IL112871A0 (en) | Structural element and methods for its manufacture | |
GB9506646D0 (en) | Antibody | |
GB9519460D0 (en) | Polyclonal antibodies and their use | |
GB9516606D0 (en) | Antibodies their preparation and use | |
GB9419312D0 (en) | Polyclonal antibodies and their use | |
GB9516137D0 (en) | Antibodies | |
IL114823A0 (en) | Fixative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971219 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990706 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 6A 61B 5/00 A, 6A 61B 10/00 B, 6A 61M 35/00 B, 6C 12Q 1/70 B, 6G 01N 33/53 B, 6C 12Q 1/68 B |
|
17Q | First examination report despatched |
Effective date: 20020130 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20050716 |